Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis
Henrik Svanström
*
, Marie Lund,
Mads Melbye
, Björn Pasternak
*
Corresponding author for this work
Department of Clinical Medicine
14
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Renal Failure
22%
Composite Endpoint
11%
Concomitant Use
100%
Cytopenia
22%
Denmark
11%
Hazard Ratio
11%
Incidence Rate
11%
Individual Outcomes
11%
Inverse Probability of Treatment Weighting
11%
Liver Toxicity
11%
Methotrexate
66%
Methotrexate Toxicity
11%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Pharmacokinetic Study
11%
Propensity Score
11%
Proportional Hazards Model
11%
Register Study
11%
Rheumatoid Arthritis
100%
Serious Adverse Events
100%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
16%
Adverse Event
100%
Base
8%
Cohort Study
8%
Cytopenia
16%
Hepatotoxicity
8%
Inflammatory Arthritis
100%
Methotrexate
100%
Non-Steroidal Anti-Inflammatory Drug
100%
Pharmacokinetic
8%
Rheumatoid Arthritis
100%